3,5-二氟-N-甲氧基-N-甲基苯甲酰胺 | 874889-34-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3,5-二氟-N-甲氧基-N-甲基苯甲酰胺
• 英文名称: 3,5-difluoro-N-methoxy-N-methylbenzamide
• 英文别名: 3,5-Difluoro-N-methoxy-N-methyl-benzamide
• CAS: 874889-34-6
• 化学式: C₉H₉F₂NO₂
• mdl: MFCD18839876
• 分子量: 201.173
• InChiKey: NAGFTAKIGZFDQR-UHFFFAOYSA-N

物化性质

• 沸点：
  305.1±32.0 °C(Predicted)
• 密度：
  1.261±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.222
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3,5-二氟-N-甲氧基-N-甲基苯甲酰胺 在 lithium hydroxide 、 正丁基锂 、 草酰氯 、 三溴化硼 、 碳酸氢钠 、 potassium carbonate 、 N,N-二甲基甲酰胺 作用下， 以 四氢呋喃 、 乙醚 、 乙醇 、 正己烷 、 二氯甲烷 、 丙酮 为溶剂， 反应 18.49h， 生成 2-[4-Chloro-2-(3,5-difluorobenzoyl)phenoxy]-1-indolin-1-yl-ethanone
  参考文献：
  名称：

  Structure−Activity Relationship Studies of Novel Benzophenones Leading to the Discovery of a Potent, Next Generation HIV Nonnucleoside Reverse Transcriptase Inhibitor

  摘要：

  Despite the progress of the past two decades, there is still considerable need for safe, efficacious drugs that target human immunodeficiency virus (HIV). This is particularly true for the growing number of patients infected with virus resistant to currently approved HIV drugs. Our high throughput screening effort identified a benzophenone template as a potential nonnucleoside reverse transcriptase inhibitor (NNRTI). This manuscript describes our extensive exploration of the benzophenone structure-activity relationships, which culminated in the identification of several compounds with very potent inhibition of both wild type and clinically relevant NNRTI-resistant mutant strains of HIV. These potent inhibitors include 70h (GW678248), which has in vitro antiviral assay IC50 values of 0.5 nM against wild-type HIV, 1 nM against the K103N mutant associated with clinical resistance to efavirenz, and 0.7 nM against the Y181C mutant associated with clinical resistance to nevirapine. Compound 70h has also demonstrated relatively low clearance in intravenous pharmacokinetic studies in three species, and it is the active component of a drug candidate which has progressed to phase 2 clinical studies.

  DOI：

  10.1021/jm050670l
• 作为产物：
  描述：

  3,5-二氟苯甲酸 在 吡啶 、 氯化亚砜 作用下， 以 二氯甲烷 为溶剂， 反应 17.0h， 生成 3,5-二氟-N-甲氧基-N-甲基苯甲酰胺
  参考文献：
  名称：

  N-(取代磺酰基)苯甲酰胺类衍生物及其制备方法和医药用途

  摘要：

  本发明涉及N‑(取代磺酰基)苯甲酰胺类衍生物及其制备方法和医药用途。具体而言，本发明涉及一种通式(I)所示的N‑(取代磺酰基)苯甲酰胺类衍生物、其制备方法及其可药用的盐，以及它们作为治疗剂，特别是作为Nav1.7抑制剂的用途，其中通式(I)中的各取代基的定义与说明书中的定义相同。

  公开号：

  CN109574927A

文献信息

• AMINE LINKED MODULATORS OF y-SECRETASE
  申请人：HO Chih Yung

  公开号：US20090105300A1

  公开（公告）日：2009-04-23

  The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, Y, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.

  本发明涉及如下所示的公式I的化合物，其中规定了A、X、Y、R1、R2、R3、R4、R5、R6、R7、R8和R9的定义。公式I的化合物可用于治疗与γ-分泌酶活性相关的疾病，包括阿尔茨海默病。
• [EN] GSM INTERMEDIATES<br/>[FR] INTERMÉDIAIRES GSM
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2009052341A1

  公开（公告）日：2009-04-23

  The present invention relates the use of compounds having the general Formula I, wherein the definitions or R1 and R2 are provided in the specification. Said compounds of Formula I are useful for the synthesis of a variety of g-secretase modulators, which are in turn useful for the treatment of diseases associated with y-secretase activity, including Alzheimer´s disease.

  本发明涉及具有通用公式I的化合物的使用，其中R1和R2的定义在说明书中提供。所述公式I的化合物可用于合成多种γ-分泌酶调节剂，这些调节剂又可用于治疗与γ-分泌酶活性相关的疾病，包括阿尔茨海默病。
• GSM INTERMEDIATES
  申请人：HO Chih Yung

  公开号：US20090306392A1

  公开（公告）日：2009-12-10

  The present invention relates the use of compounds having the general Formula I, wherein the definitions or R 1 and R 2 are provided in the specification. Said compounds of Formula I are useful for the synthesis of a variety of γ-secretase modulators, which are in turn useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.

  本发明涉及具有一般式I的化合物的使用，其中在说明书中提供了R1和R2的定义。公式I的这些化合物对于合成各种γ-分泌酶调节剂非常有用，这些调节剂又对于治疗与γ-分泌酶活性相关的疾病，包括阿尔茨海默病，非常有用。
• Amine linked modulators of γ-secretase
  申请人：Janssen Pharmaceutica N.V.

  公开号：US08247610B2

  公开（公告）日：2012-08-21

  The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, Y, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.

  本发明涉及以下式子的化合物（I），其中A、X、Y、R1、R2、R3、R4、R5、R6、R7、R8和R9的定义在说明书中给出。式子（I）的化合物对于治疗与γ-分泌酶活性有关的疾病，包括阿尔茨海默病，是有用的。
• Selective C–H Iodination of Weinreb Amides and Benzamides through Iridium Catalysis in Solution and under Mechanochemical Conditions
  作者：Amparo Sanz-Marco、Beatriz Saavedra、Elis Erbing、Jesper Malmberg、Magnus J. Johansson、Belén Martín-Matute

  DOI：10.1021/acs.orglett.3c03190

  日期：2024.4.12

  The acid mediated ortho-iodination of Weinreb amides using a readily available catalyst is described. The selective ortho-iodination of Weinreb amides, challenging substrates in directed C–H activations, and also of benzamides is achieved. The process works under mild conditions and tolerates air and moisture, having a great potential for industrial applications. The methodology can be applied under

  描述了使用容易获得的催化剂对 Weinreb 酰胺进行酸介导的邻位碘化。实现了 Weinreb 酰胺、定向 C-H 激活中具有挑战性的底物以及苯甲酰胺的选择性邻位碘化。该工艺在温和的条件下工作，能够耐受空气和湿气，具有巨大的工业应用潜力。该方法可以在机械化学条件下应用，保持反应结果和选择性。